DRKS00010560招募中不适用
THIAMAT-Local Ablative Therapy of Hepatic Malignomas - Proximity to untreated tumor tissue - THIAMAT
Klinik und Poliklinik für Radiologie Klinikum der Universität München0 个研究点目标入组 100 人开始时间: 2017年8月29日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- All
入选标准
- •hepatocellular carcinoma or hepatic metastatic colorectal cancer or hepatic metastatic disease
- •male or female,> 18 years
- •Indication for local ablation (RFA, HDR brachytherapy, microwave therapy) in two or more sessions
- •Approval of all study procedures participate
- •Signed informed consent
- •Chemotherapy paused for min. 2 weeks before the confinement
- •cortisone paused for at least 2 weeks prior to confinement
排除标准
- •contraindication for local ablation of liver
- •Extrahepatic tumor manifestations before local Ablation treatment
- •Life expectancy <3 months
- •hepatic tumor volume> 70%
- •chronic infections (except HBV / HCV infections in HCC patients)
- •pronounced ascites
- •contraindications for MRI contrast agent (Gd-EOB-DTPA), X-ray contrast agents, MRI and CT
- •Cirrhosis (in hepatocellular carcinoma allowed)
- •status post papilla resection / DHC stent / biliary manipulation
- •severe cardiovascular disease (NYHA III / IV)
- •thrombotic or embolic events in the past 6 months (stroke / TIA)
- •severe hemorrhages in the last 3 months
- •second malignancy within the last 5 years
- •immunosuppression (e.g. in status post transplantation) or HIV, in particular cortisone
- •autoimmune disease or inflammatory bowel disease
- •cortisone therapy duration
研究者
相似试验
已完成
不适用
A treatment algorithm for Hepatic Angiomyolipomas: a long-term follow-up study and a systematic reviewbenign liver tumorMesenchymal tumor1001981510019818NL-OMON44998Erasmus MC, Universitair Medisch Centrum Rotterdam9
进行中（未招募）
1 期
Panitumumab after Resection of Liver Metastases from Colorectal Cancer in RAS Wild-type Patients-PARLIMPatients with metastatic colorectal cancer confined to the liver who underwent R0/1 resection of liver metastasesMedDRA version: 21.0Level: LLTClassification code 10052362Term: Metastatic colorectal cancerSystem Organ Class: 100000004864EUCTR2010-023671-26-DEKlinikum der Universität München-Großhadern111
进行中（未招募）
1 期
Panitumumab after Resection of Liver Metastases from Colorectal Cancer in RAS Wild-type Patients-PARLIMPatients with metastatic colorectal cancer confined to the liver who underwent R0/1 resection of liver metastasesMedDRA version: 20.0Level: LLTClassification code 10052362Term: Metastatic colorectal cancerSystem Organ Class: 100000004864EUCTR2010-023671-26-ATKlinikum der Universität München-Großhadern111
已完成
2 期
DEBIRIliver metastasis from colorectal cancerJPRN-jRCTs051200042Koichiro Yamakado35
已完成
不适用
ocal ablation of liver and lung metastases in patients with colorectal cancer after failure of first- or later-line systemic chemotherapy – a prospective trialC18C19C20Malignant neoplasm of colonMalignant neoplasm of rectosigmoid junctionMalignant neoplasm of rectumDRKS00006295niversitätsklinikum Magdeburg152